Comparing Bright Green (NASDAQ:BGXX) & MariMed (OTC:MRMD)

Bright Green (NASDAQ:BGXX) and MariMed (OTC:MRMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk.

Analyst Ratings

This is a breakdown of current ratings and price targets for Bright Green and MariMed, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bright Green	0	0	0	0	0.00
MariMed	0	0	0	1	4.00

Given Bright Green’s higher probable upside, equities analysts clearly believe Bright Green is more favorable than MariMed.

Valuation & Earnings

This table compares Bright Green and MariMed”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bright Green	N/A	N/A	-$13.13 million	($0.06)	N/A
MariMed	$148.60 million	0.21	-$16.03 million	($0.03)	-2.66

Bright Green has higher earnings, but lower revenue than MariMed. MariMed is trading at a lower price-to-earnings ratio than Bright Green, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Bright Green and MariMed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bright Green	N/A	-88.37%	-55.30%
MariMed	-8.95%	1.58%	0.53%

Risk & Volatility

Bright Green has a beta of -0.26, meaning that its stock price is 126% less volatile than the S&P 500. Comparatively, MariMed has a beta of 3.15, meaning that its stock price is 215% more volatile than the S&P 500.

Insider & Institutional Ownership

7.8% of Bright Green shares are owned by institutional investors. Comparatively, 0.2% of MariMed shares are owned by institutional investors. 62.5% of Bright Green shares are owned by insiders. Comparatively, 19.0% of MariMed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

MariMed beats Bright Green on 7 of the 13 factors compared between the two stocks.

About Bright Green

Bright Green Corporation focuses on the cultivation, manufacture, and sale of cannabis and cannabis-related products. Its products are used in research, pharmaceutical applications, and affiliated exports. The company was incorporated in 2019 and is based in Grants, New Mexico.

About MariMed

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.